deltatrials
Terminated NA INTERVENTIONAL 2-arm NCT03438877

Intensive Versus Regular Dosage For PD In AKI.

Intensive Versus Regular Dosage For Peritoneal Dialysis In Non-Hypercatabolic Acute Kidney Injury, A Multicenter Randomized Controlled Trial

Sponsor: Peking University First Hospital

Conditions Acute Kidney Injury Peritoneal Dialysis
Interventions Intensive dosage of PD Regular dosage of PD
Updated 11 times since 2018 Last updated: Nov 24, 2021 Started: Sep 29, 2018 Primary completion: Dec 26, 2019 Completion: Dec 26, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Patients recruited difficult.

Other terminated trials from Peking University First Hospital

See all terminations from Peking University First Hospital

Other Acute Kidney Injury trials with similar outcome

Browse all Acute Kidney Injury trials

A NA clinical study on Acute Kidney Injury and Peritoneal Dialysis, this trial is terminated or withdrawn. The trial is conducted by Peking University First Hospital and has accumulated 11 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotNot Yet Recruiting~Jun 2018 – ~Feb 2019 · 8 months · monthly snapshotNot Yet Recruiting~Feb 2019 – ~Sep 2019 · 7 months · monthly snapshotRecruiting~Sep 2019 – ~Oct 2019 · 30 days · monthly snapshotRecruiting~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshotRecruiting~Nov 2019 – ~Jan 2021 · 14 months · monthly snapshotRecruiting~Jan 2021 – ~Nov 2021 · 10 months · monthly snapshotRecruiting~Nov 2021 – ~Jan 2022 · 2 months · monthly snapshotUnknown Status~Jan 2022 – ~Jul 2024 · 30 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 23 months · monthly snapshotTerminated

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Jan 2022 — Jul 2024 [monthly]

    Terminated NA

    Status: Unknown Status → Terminated

  4. Nov 2021 — Jan 2022 [monthly]

    Unknown Status NA

    Status: Recruiting → Unknown Status

  5. Jan 2021 — Nov 2021 [monthly]

    Recruiting NA

▶ Show 6 earlier versions

  1. Nov 2019 — Jan 2021 [monthly]

    Recruiting NA

  2. Oct 2019 — Nov 2019 [monthly]

    Recruiting NA

  3. Sep 2019 — Oct 2019 [monthly]

    Recruiting NA

  4. Feb 2019 — Sep 2019 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  5. Jun 2018 — Feb 2019 [monthly]

    Not Yet Recruiting NA

  6. Mar 2018 — Jun 2018 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Peking University First Hospital
Data source: Peking University First Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations